Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent

Arthritis and Rheumatism

Volumn 56, Issue 2, 2007, Pages 498-508

  Srinivasan, Mythily ^b   Eri, Rajaraman ^c   Zunt, Susan L ^c   Summerlin, Don John ^c   Brand, David D ^a   Blum, Janice S ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BINDING PROTEIN; CD80 BINDING COMPETITIVE ANTAGONIST PEPTIDE; COLLAGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROLINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MOTIF; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; APOPTOSIS; ARTHRITIS, RHEUMATOID; BINDING, COMPETITIVE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-6; MICE; MICE, INBRED DBA; NEUTROPHIL INFILTRATION; PEPTIDES; SYNOVIAL MEMBRANE;

EID: 33847070378     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22324     Document Type: Article

References (44)

1. VanderBorght A, Geusens P, Raus J, Stinissen P. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies [review]. Semin Arthritis Rheum 2001;31:160-75.
2. Keir ME, Sharpe AH. The B7/CD28 costimulatory family in autoimmunity [review]. Immunol Rev 2005;204:128-43.
3. Kremer JM, Dougados M, Emery P, Durez P, Sibilia J, Shergy W, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial [published erratum appears in Arthritis Rheum 2005;52:3321]. Arthritis Rheum 2005;52:2263-71.
4. Erbe DV, Wang S, Xing Y, Tobin JF. Small molecule ligands define a binding site on the immune regulatory protein B7.1. J Biol Chem 2002;277:7363-8.
5. Huxley P, Sutton DH, Debnam P, Matthews IR, Brewer JE, Rose J, et al. High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy. Chem Biol 2004;11:1651-8.
6. Srinivasan M, Roeske RW. Immunomodulatory peptides from IgSF proteins: a review. Curr Protein Pept Sci 2005;6:185-96.
7. Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation [review]. Nat Immunol 2002;3:427-34.
8. Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses [published erratum appears in Nature 2001;411:617]. Nature 2001;410:608-11.
9. Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001;410:604-8.
10. Bhattacharyya R, Chakrabarti P. Stereospecific interactions of proline residues in protein structures and complexes. J Mol Biol 2003;331:925-40.
11. Srinivasan M, Lu D, Eri R, Brand DD, Haque A, Blum JS. CD80 binding polyproline helical peptide inhibits T cell activation. J Biol Chem 2005;280:10149-55.
12. Youngnak P, Kozono Y, Kozono H, Iwai H, Otsuki N, Jin H, et al. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 2003;307:672-7.
13. Kato F, Nomura M, Nakamura K. Arthritis in mice induced by a single immunisation with collagen. Ann Rheum Dis 1996;55:535-9.
14. Latham KA, Whittington KB, Zhou R, Qian Z, Rosloniec EF. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints. J Immunol 2005;174:3978-85.
15. Svendsen P, Andersen CB, Willcox N, Coyle AJ, Holmdahl R, Kamradt T, et al. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J Immunol 2004;173:7037-45.
16. Tellender AC, Pettersson U, Runstrom A, Andersson M, Michaelsson E. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis: limited role of IFN-γ in anti-B7-mediated suppression of disease. J Autoimmun 2001;17:39-50.
17. Iwai H, Kozono Y, Hirose S, Akiba H, Yagita H, Okumura K, et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 2002;169:4332-9.
18. Barck KH, Lee WP, Diehl LJ, Ross J, Gribling P, Zhang Y, et al. Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis. Arthritis Rheum 2004;50:3377-86.
19. Sasai M, Saeki Y, Ohshima S, Nishioka K, Mima T, Tanaka T, et al. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum 1999;42:1635-43.
20. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J Clin Invest 1989;83:1267-76.
21. Caminschi I, Lucas KM, O'Keeffe MA, Hochrein H, Laabi Y, Kontgen F, et al. Molecular cloning of F4/80-like-receptor, a seven-span membrane protein expressed differentially by dendritic cell and monocyte-macrophage subpopulations. J Immunol 2001; 167:3570-6.
22. Srinivasan M, Gienapp IE, Stuckman SS, Rogers CJ, Jewell SD, Kaumaya PT, et al. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28. J Immunol 2002;169:2180-8.
23. Van der Merwe PA. Modeling costimulation. Nat Immunol 2000; 1:194-5.
24. Webb LM, Walmsley MJ, Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 1996;26:2320-8.
25. Dong C, Flavell RA. Cell fate decision: T-helper 1 and 2 subsets in immune responses [review]. Arthritis Res 2000;2:179-88.
26. Orabona C, Grohmann U, Belladonna ML, Fallarino F, Vacca C, Bianchi R, et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol 2004;5:1134-42.
27. Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, et al. CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 1999;162:203-8.
28. Broeren CP, Gray GS, Carreno BM, June CH. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J Immunol 2000;165:6908-14.
29. Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol 1998;161:2762-71.
30. Aarvak T, Natvig JB. Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis [review]. Arthritis Res 2001;3:13-7.
31. Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003;349:1907-15.
32. Thomas R, McIlraith M, Davis L, Lipsky P. Rheumatoid synovial T cells are functionally active and can contribute to the pathogenesis of rheumatoid arthritis: comment on the article by Matthews et al [letter]. Arthritis Rheum 1994;37:445-6.
33. Verwilghen J, Lovis R, De Boer M, Linsley PS, Haines GK, Koch AE, et al. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J Immunol 1994;153:1378-85.
34. McHugh RS, Ratnoff WD, Gilmartin R, Sell KW, Selvaraj P. Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1. Clin Immunol Immunopathol 1998;87:50-9.
35. Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC. Baeten D, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:834-8.
36. Fedorov AA, Fedorov E, Gertler F, Almo SC. Structure of EVH1, a novel proline-rich ligand-binding module involved in cytoskeletal dynamics and neural function. Nat Struct Biol 1999;6:661-5.
37. Larson SM, Davidson AR. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures. Protein Sci 2000;9:2170-80.
38. Joe B, Griffiths MM, Remmers EF, Wilder RL. Animal models of rheumatoid arthritis and related inflammation [review]. Curr Rheumatol Rep 1999;1:139-48.
39. Taneja V, Taneja N, Behrens M, Griffiths MM, Luthra HS, David CS. Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice. J Immunol 2005;174:1118-25.
40. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996;39:115-24.
41. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995;3:87-98.
42. Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, et al. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation 2001;72:1423-32.
43. Lumsden JM, Prasad SJ, Peach RJ, Ronchese F. The effects of B7-dependent costimulation on T cell division and survival in vivo and in vitro are dependent on antigen concentration. Eur J Immunol 2003;33:2074-82.
44. Gao JX, Chang X, Zheng X, Wen J, Yin L, Du P, et al. A new role for CD28 in the survival of autoreactive T cells in the periphery after chronic exposure to autoantigen. Int Immunol 2004;16:1403-9.